ClinTec International Presents
Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features
2010 Commonwealth Games ~ 2010 Nobel Prizes ~ Sachin Tendulkar ~ Rajasthan Royals ~ Kings XI Punjab ~ Sushil Kumar ~ Deepika Kumari ~ Somdev Devvarman ~ HR Bhardwaj
Home / India News / 2007 / January / January 16, 2007
ClinTec International Presents Strategy for Indian Pharma Companies to Achieve Global Competitive Edge, at Global Healthcare Conference

Top News

144 Section in Hyderabad ahead of Ayodhya verdict

Manmohan Singh to campaign in Bihar today

FBI failed to act on Headley's wife's terror link expose 3 yrs before Mumbai attacks

Craven's horror flicks 'were inspired by real stories'

RBI will intervene if inflows turn lumpy: Subbarao

Enforcement Directorate issues 'Look Out Circular' against Lalit Modi

Now, laser technology that destroys tumours using heat

Waist size, not BMI can foretell cardiovascular risk in children

ClinTec International Presents Strategy for Indian Pharma Companies to Achieve Global Competitive Edge, at Global Healthcare Conference

New Delhi, Delhi, India

ClinTec International Ltd presents at Global Healthcare Conference "Promoting Partnerships", New Delhi, India. The presentation detailed a strategy for Indian drug development companies to achieve competitive advantage through Partnership with UK service providers to the Pharma industry. The presentation was delivered by Dr. Rabinder Buttar, President and Founder of ClinTec International.

The Pharmaceutical sector is experiencing challenges globally along the key dimensions of Cost, Time and Resource. The spiraling cost of global drug development and associated financial exposure, have led Pharma companies to seek innovative ways of lowering their risk profile. Reducing the cost of drug development has led service providers to the Pharma industry and Contract Research Organizations (CRO's) in particular, to seek emerging markets where the cost of labor is a fraction of the cost of that in the Western world.

Global pharmaceutical companies can combat these key challenges of drug development through partnering with international CRO's who have not only a presence in Europe and the US close to the Client Headquarters, but also a well established and credible presence in India where there are viable solutions to these challenges.

India is gaining acceptance as recognized destination for international clinical research and drug development programs. The cost of labor is significantly lower than traditional US and European markets for clinical research. Time-to-market is reduced through rapid patient recruitment, driven by a representation of patients from a wide range of therapeutic conditions. Challenges remain in the wide availability of qualified clinical research resource in India, where demand significantly outstrips supply. This is actively being addressed by Indian Pharma companies and CRO's through ensuring that their employees are trained to international clinical research standards. Ensuring that Indian staff performs key roles in International teams further addresses the skills gap and breaks down any myths of India only being a destination for the 'back-office'.

A strategy for Indian drug development is proposed which combines the best expertise available, regardless of geographical location. Indian Pharma companies as they race for bringing New Chemical Entities to the global marketplace can increase their chances of success by fully integrating the best expertise in the western world into their own armory. Indian Pharma companies can form partnerships with agile international CRO's in order to get access to global sales channels, regulatory expertise and international clinical research capabilities. Through partnership, the risk and reward is shared with the goal of bringing new drugs to market as efficiently as possible for mutual benefit.

ClinTec International is a success story of forming winning combinations between UK and Indian companies. In September 2006, ClinTec International and Dr Reddy's Laboratories signed a collaboration agreement to co-develop an anti-cancer compound DRF 1042. This agreement signaled the move from a straight service provider relationship to a partnership model between ClinTec International and Dr Reddy's.

Director of Corporate Development at ClinTec International, Mr. Bobby Bal, said, "The world is becoming a very small place. Companies which will move ahead are those that break geographical and cultural barriers, with the objective of sourcing the best functional expertise regardless of location, and combining them into winning global teams. Forming high-performing international teams is our core business, and India as an emerging powerhouse in international business coupled with the numerous benefits to clinical research, becomes a core country in our global strategy".

Dr Rabinder Buttar, President & CEO of ClinTec International, said, "ClinTec International in it's pioneering spirit took a lead role in establishing a footprint in India before most other international CRO's. We are now seeing the fruits of this foresight come through, as Indian clinical research professionals lead the development of strategically important drugs for western pharmaceutical companies. We believe that Indian Pharma companies will increasingly look to execute their clinical development programs in Europe and the US as they realize their long-term vision of being innovative global players with new drugs to offer, to combine with their traditional Generic Drug capabilities. The two-way communication and partnership commitment between UK and Indian MNC's in the Pharma sector will have lucrative mutual rewards."

About ClinTec International

ClinTec International is a privately owned full service global clinical research organization, which was founded in 1997 by Dr Rabinder Buttar, the company's President & CEO. ClinTec International is headquartered in Windsor, UK and has a presence in India through it's well established Indian office. ClinTec clinical research is ongoing in more than 30 countries in Europe, US, Middle East, North and South Africa and Latin America. In addition to ClinTec' vast expertise in oncology, it has also conducted over a 150 clinical trials in many other therapeutic areas including anti-infectives, cardiology, dermatology, gastroenterology, neurology, respiratory medicine and rheumatology. ClinTec International excels in conducting clinical studies in diverse geographical locations, supported by a team of world class project managers and clinical research associates. ClinTec International's 'fast, flexible and focused' approach to clinical research ensures an added advantage to the complex and costly process of new drug development.

Bobby Bal, Director Corporate Development, ClinTec International Ltd, +4 (0) 1753 834 060

Source: ClinTec International (Business Wire India)

Press release presented here is sourced from the Source mentioned above and is provided on as-is basis. Please contact the Company / Source directly for any further information in regard to this release. This website will be unable to assist you in regard to the accuracy or correctness of information in this release.

India News / Press Releases on January 16, 2007

Egyptian Government and Business Delegation visits Convergys' Hyderabad Facility
Business Wire India

Chinese Telematics and Infotainment Market Set for High Growth in the Next Five Years
Business Wire India

AAPKAVIDEO.COM Forays Deeper into the Indian Web 2.0 Space
Business Wire India

Local Medium Size Formulator Segments Appear Promising for Personal Care Specialty Surfactant Market
Business Wire India

Amul Launches India's First Pro-Biotic Wellness Ice-Cream and Sugar Free Delight for Diabetics
Business Wire India

ClinTec International Presents Strategy for Indian Pharma Companies to Achieve Global Competitive Edge, at Global Healthcare Conference
Business Wire India

Hyundai Verna Receives Accolades from the Industry
Business Wire India

Rediff.Com CFO Joy Basu, Named a Winner In The 6th Annual CFO Awards, 2006
Business Wire India

Also see International News / Press Releases on January 16, 2007

Suggested pages for your additional reading on Facebook

© 2000-2018 All Rights Reserved and are of their respective owners.
Disclaimer, Terms of Service & Privacy Policy | Contact Us